semaglutide compounding lawsuit news Compound versions of GLP-1 drugs for weight loss halted by FDA Drugmakers battle pharmacies over compounded

Genetics, diet, exercise, starting weight, metabolic health, and adherence all influence individual outcomes

Clinical trial data from the STEP 1 extension study showed that after discontinuing semaglutide 2.4 mg, approximately two-thirds of weight loss was regained within one year

The significance of a 6.8 mmHg reduction extends beyond the raw number

The Truth About Wisconsin Winter Weight Gain and How GLP-1 Telehealth Can Help The arrival of a Wisconsin winter brings with it cozy sweaters, holiday feasts, and, for many, the annual struggle with winter weight gain

GLP-1 receptor agonists have been shown to decrease binge drinking and lessen overall alcohol consumption

This formulation uses microsphere technology to provide sustained release of exenatide over seven days